Human Health

Find out more about the drug discovery process at Boehringer Ingelheim

Cardiovascular disease, including heart disease and stroke, is a major global health concern and the leading cause of death and disability worldwide.

View this Section

About 425 million adult people in the world are living with diabetes, with Type 2 diabetes accounting for 90 – 95 percent of all cases. This number is projected to increase to 629 million people by 2045.

View this Section

Cancer takes. Takes away time. Takes away loved ones. At Boehringer Ingelheim we are providing new hope for patients by taking cancer on.

View this Section

Boehringer Ingelheim has 100 years of heritage in respiratory disease. Since 1921 we have emerged as a leader in this disease area.

View this Section

Living with inflammatory and fibrotic diseases greatly impacts patients’ lives, both physically and emotionally. These patients guide and inspire us to turn innovative science into life-changing medical breakthroughs.

View this Section

Central nervous system (CNS) diseases, including schizophrenia or Alzheimer’s disease, are a focus of Boehringer Ingelheim discovery research and development.

View this Section

At Boehringer Ingelheim, we have expanded our global research and development activities to tackle eye diseases. Visual impairment and blindness have a profound and devastating impact on the lives of the affected person.

View this Section

The lives of animals and humans are interconnected in deep and complex ways. We know that when animals are healthy, humans are healthier, too. By delivering value through innovation, we enhance the well-being of both.

View this Section